<DOC>
	<DOCNO>NCT01669265</DOCNO>
	<brief_summary>This retrospective , multicentric cohort study patient case cT1-3 , N0 early breast cancer , previously intraoperative sentinel lymph node ( SLN ) evaluation one-step nucleic acid amplification ( OSNA ) assay complete axillary dissection . The aim present study assess intraoperative positive SLN total tumor load ( TTL ) obtain OSNA assay determine whether TTL predict non-SLN metastasis patient clinically node-negative early-stage breast cancer .</brief_summary>
	<brief_title>Sentinel Lymph Node Total Tumoral Load Predictor Non Sentinel Node Involvement Early Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Pathologically confirm invasive breast carcinoma Stage T13 , N0 evaluate physical exam image accord AJCC v.7 best clinical local practice Intraoperative evaluation sentinel lymph node ( SLN ) OSNA Complete dissection axillary lymph node evaluation SLNs OSNA Pathology report tumor dissect lymph node include follow information : primary tumor size ( mm ) , tumor grade ( ScarffBloom Richardson ) , estrogen receptor status progesterone receptor status HER2 status ( ASCO/CAP guideline ) Ki67 index presence/absence lymphovascular invasion total number sentinel nonsentinel lymph node dissect surgery total number positive negative sentinel nonsentinel lymph node , *size metastasis sentinel nonsentinel lymph node total tumoral load sentinel lymph node , express number CK19 mRNA copy per microliter . Patients underwent neoadjuvant chemotherapy CK19negative breast tumor ALND &lt; 10 lymph node In situ carcinoma Metastatic breast cancer time diagnosis</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>OSNA</keyword>
	<keyword>sentinel lymph node</keyword>
</DOC>